Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butanvac Booster in Adults
NCT05354024Phase 3Completed
- Sponsor
- Instituto Butantan
- Start
- Feb 2023
- Primary completion
- Oct 2023
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Patria in coronavirus disease 2019 (COVID-19), sponsored by Instituto Butantan. Started Feb 2023; status: completed.
02
Drugs
Patria
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05354024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05354024.